Anti-cardiolipin antibodies (aCL) of the IgG isotype are significantly associated with recurrent venous thromboses in patients with the antiphospholipid syndrome (APS). it is now widely accepted that the aCL antibodies that are present in the APS are actually directed against phospholipid-binding proteins, specifically 1beta2-Glycoprotein I (beta2GPI) and prothrombin. Since the presence of CD4+ T cells is generally required for production of IgG antibodies, perhaps CD4+ T cells with specificity for (beta2GPI may participate in the production of pathogenic aCL in APS. In this regard, I have recently shown that beta2GPI-specific T cells are present in APS patients. Moreover, co-culture of patient peripheral blood mononuclear cells (PBMCs) with beta2GPI results in the upregulation of monocyte procoagulant activity (PCA) and this is reliant on CD4+ T cells. in this context, the goal of the D and F funding is to generate short-term beta2GPI-specific T cell lines to determine their functional role in APS. The long-term goal is to generate monoclonal T cell lines specific to beta2GPI and use these cell lines as a tool to dissect the cellular aspects of the APS response.
The aims of this study are: 1. To generate short-term beta2GPI-specific CD4+ T call lines from APS patients 2. To study the functional activity of beta2GPI-specific CD4+ T cell lines on B cells and monocytes, and characterize the phenotypes of these T cells 3. To define epitopes for beta2GPI-specific T cell lines

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Comprehensive Center (P60)
Project #
5P60AR036834-13
Application #
6346736
Study Section
Special Emphasis Panel (ZAR1-AAA-C (M1))
Project Start
1987-07-15
Project End
2002-06-30
Budget Start
Budget End
Support Year
13
Fiscal Year
2000
Total Cost
$159,355
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Jawaheer, Damini; Maranian, Paul; Park, Grace et al. (2010) Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter? J Rheumatol 37:2475-85
Ranganath, Veena K; Yoon, Jeonglim; Khanna, Dinesh et al. (2007) Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Ann Rheum Dis 66:1633-40
Kahn, Katherine L; MacLean, Catherine H; Liu, Honghu et al. (2007) The complexity of care for patients with rheumatoid arthritis: metrics for better understanding chronic disease care. Med Care 45:55-65
Kahn, K L; Maclean, C H; Wong, A L et al. (2007) Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort. Arthritis Rheum 57:707-15
Kahn, K L; MacLean, C H; Liu, H et al. (2006) Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice. Arthritis Rheum 55:884-91
Paulus, Harold E; Oh, MyungShin; Sharp, John T et al. (2004) Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal. Arthritis Rheum 50:1083-96
Liu, Honghu; Harker, Judith O; Wong, Andrew L et al. (2004) Case finding for population-based studies of rheumatoid arthritis: comparison of patient self-reported ACR criteria-based algorithms to physician-implicit review for diagnosis of rheumatoid arthritis. Semin Arthritis Rheum 33:302-10
Riemekasten, Gabriela; Langnickel, Dirk; Enghard, Philipp et al. (2004) Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells. J Immunol 173:5835-42
La Cava, Antonio; Ebling, Fanny M; Hahn, Bevra H (2004) Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol 173:3542-8
Amjadi-Begvand, Sogol; Khanna, Dinesh; Park, Grace S et al. (2004) Dating the ""window of therapeutic opportunity"" in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset. J Rheumatol 31:1686-92

Showing the most recent 10 out of 111 publications